ATE353213T1 - Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren - Google Patents

Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren

Info

Publication number
ATE353213T1
ATE353213T1 AT92918509T AT92918509T ATE353213T1 AT E353213 T1 ATE353213 T1 AT E353213T1 AT 92918509 T AT92918509 T AT 92918509T AT 92918509 T AT92918509 T AT 92918509T AT E353213 T1 ATE353213 T1 AT E353213T1
Authority
AT
Austria
Prior art keywords
agglomerates
weight
isobutylphenyl
pct
propionic acid
Prior art date
Application number
AT92918509T
Other languages
German (de)
English (en)
Inventor
Graham John Atkin
Peter Drew
John Leslie Turner
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Application granted granted Critical
Publication of ATE353213T1 publication Critical patent/ATE353213T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92918509T 1991-09-06 1992-08-25 Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren ATE353213T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119052A GB9119052D0 (en) 1991-09-06 1991-09-06 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE353213T1 true ATE353213T1 (de) 2007-02-15

Family

ID=10700981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92918509T ATE353213T1 (de) 1991-09-06 1992-08-25 Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren

Country Status (16)

Country Link
US (1) US5512302A (OSRAM)
EP (1) EP0602112B1 (OSRAM)
JP (1) JP3444597B2 (OSRAM)
KR (1) KR100253046B1 (OSRAM)
AT (1) ATE353213T1 (OSRAM)
AU (1) AU655673B2 (OSRAM)
CA (1) CA2116956C (OSRAM)
CZ (1) CZ282271B6 (OSRAM)
DE (1) DE69233678T2 (OSRAM)
FI (1) FI107878B (OSRAM)
GB (1) GB9119052D0 (OSRAM)
IL (1) IL103005A (OSRAM)
IN (1) IN174169B (OSRAM)
RU (1) RU2123841C1 (OSRAM)
WO (1) WO1993004676A1 (OSRAM)
ZA (1) ZA926709B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101039B (fi) * 1992-10-09 1998-04-15 Eeva Kristoffersson Menetelmä lääkepellettien valmistamiseksi
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6726929B1 (en) 1998-12-18 2004-04-27 Basf Aktiengesellschaft Pharmaceutical mixture comprising a profen
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6251945B1 (en) * 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
DE19901692C2 (de) * 1999-01-18 2002-06-20 Gruenenthal Gmbh Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes
DE10003757A1 (de) 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
RU2164796C1 (ru) * 2000-05-25 2001-04-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Противогистаминное средство и способ его получения
US20040173147A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
US20040173146A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
US6962715B2 (en) * 2001-10-24 2005-11-08 Hewlett-Packard Development Company, L.P. Method and dosage form for dispensing a bioactive substance
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
GB0312419D0 (en) * 2003-05-30 2003-07-02 Boots Healthcare Int Ltd Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
RU2254854C2 (ru) * 2003-09-08 2005-06-27 Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" Анальгезирующий, жаропонижающий, противовоспалительный препарат и способ его получения
US20050202051A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical vehicle
US20050203482A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical dispensing apparatus and method
JP2008266270A (ja) * 2007-04-25 2008-11-06 Kowa Co イブプロフェン、トラネキサム酸及び糖アルコールを含有する固形製剤
PT3220916T (pt) 2014-11-17 2023-06-26 Eisai R&D Man Co Ltd Método para tratamento de cancro com n-((4,6-dimetil-2-oxo-1,2-di-hidropiridina-3-il)metil)-5-(etil(tetrahidro-2h-piran-4-il) amino)-4-metil-4'-(morfolinometil)-[1,1'-bifenilo]-3-carboxamida

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92752T1 (de) * 1987-07-08 1993-08-15 American Home Prod Spruehgetrocknete ibuprofen-zusammensetzungen.
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
US5266723A (en) * 1989-05-16 1993-11-30 Medice, Ltd., Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
US5332834A (en) * 1992-12-02 1994-07-26 Hoechst Celanese Corporation Racemization of an enantomerically enriched α-aryl carboxylic acid

Also Published As

Publication number Publication date
CZ282271B6 (cs) 1997-06-11
US5512302A (en) 1996-04-30
EP0602112B1 (en) 2007-02-07
FI107878B (fi) 2001-10-31
WO1993004676A1 (en) 1993-03-18
ZA926709B (en) 1993-04-28
DE69233678T2 (de) 2008-01-24
FI941046A7 (fi) 1994-03-04
CZ49994A3 (en) 1994-07-13
IN174169B (OSRAM) 1994-10-01
RU2123841C1 (ru) 1998-12-27
AU655673B2 (en) 1995-01-05
FI941046A0 (fi) 1994-03-04
GB9119052D0 (en) 1991-10-23
CA2116956A1 (en) 1993-03-18
DE69233678D1 (de) 2007-03-22
CA2116956C (en) 2002-07-16
KR100253046B1 (ko) 2000-05-01
EP0602112A1 (en) 1994-06-22
IL103005A0 (en) 1993-01-31
AU2487092A (en) 1993-04-05
JPH06510532A (ja) 1994-11-24
JP3444597B2 (ja) 2003-09-08
IL103005A (en) 1996-01-19

Similar Documents

Publication Publication Date Title
ATE353213T1 (de) Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren
DE69105106T2 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
DE69916922T2 (de) Ibuprofenhaltige Arzneizubereitung
JP4017661B2 (ja) 重合体マトリックス中の作用物質の固溶体の形の作用物質調剤の製法及び該製法により製造された作用物質調剤
DE69424487T2 (de) Formulierung enthaltend einen antibakteriellen und einen Antiulcus Wirkstoff
JP2628231B2 (ja) 放出調整賦形剤として容易に入手できるコンニャクグルコマンナン
AU2002238848B2 (en) Use of a spray-dried powder comprising a sugar alcohol
WO1986002834A1 (en) Pharmaceutical preparations in the form of instant granules or tablets, and process for their manufacture
RU94019417A (ru) Способ получения фармацевтической композиции, фармацевтическая композиция, фармацевтический препарат, способы получения фармацевтического препарата
KR960016204B1 (ko) 비스테로이드성 소염제를 함유하는 약제학적 제제
AU670048B2 (en) Immediate-effect ibuprofen-containing medicament and its use
EP0559645A1 (en) Composition for solid pharmaceutical preparations containing active vitamins d 3? and process for preparation thereof
DD300404A5 (de) Pharmazeutische zubereitung
JPS59181224A (ja) 安定なインタ−フエロン製剤の製法
JPH0813736B2 (ja) 単斜結晶構造を有する熱―、光―、及び湿気―感受性活性成分を含む錠剤又は糖剤組成物の調製方法
Rojas Excipient design by co-processing for direct compression applications
DE69910188T2 (de) Arzneiformen enthaltend carvedilol
JP2891744B2 (ja) パントテン酸カルシウム組成物およびその製造方法
MXPA05010254A (es) Composicion farmaceutica que contiene complejo de platino como sustancia activa y metodo de fabricacion de la misma.
Crowley et al. Drug-fatty acid salt with wax-like properties employed as binder in melt granulation
Hautala et al. Evaluation of new flavors for feline mini-tablet formulations.
DE60024132T2 (de) Einen histamin h 2 antagonisten enthaltende brausezusammensetzung
JP2004075594A (ja) 経口用ウコン類組成物
JPH10298074A (ja) ビタミン類含有組成物
KR101476096B1 (ko) 용해도가 향상된 쎄레콕시브의 약제학적 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0602112

Country of ref document: EP

REN Ceased due to non-payment of the annual fee